Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.79 |
| ▸ | MAPT | P10636 | 4/20 | 0.79 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.79 |
| ▸ | TP53 | P04637 | 3/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.79 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.79 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.79 |
| ▸ | THPO | P40225 | 1/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.79 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.59 |
| ▸ | GMNN | O75496 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11973504 | 1.00 | MEN1 (0.79) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL28525260 | 1.00 | MEN1 (0.79) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL997303 | 1.00 | MEN1 (0.79) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL15050371 | 1.00 | MEN1 (0.79) | MEN1KMT2AMAPTSLC25A20TP53 | |
| Hydrochloric Acid SCHEMBL28705824 | 0.99 | MEN1 (0.77) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL14931520 | 0.98 | MEN1 (0.76) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL787164 | 0.94 | MEN1 (0.74) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL8593280 | 0.94 | MEN1 (0.74) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL18075036 | 0.94 | MEN1 (0.88) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL16344748 | 0.94 | MEN1 (0.88) | MEN1KMT2AMAPTSLC25A20TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235969-A2 | METHODS OF TREATMENT USING BIOMARKER-GUIDED PLASMAPHERESIS | CIRCULATE HEALTH, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250314660-A1 | METABOLIC BIOMARKERS FOR ASSESSING FRIEDREICH'S ATAXIA IN A SUBJECT | THE TRUSTEES OF INDIANA UNIVERSITY | 2025-10-09 | — | — | US | disclosed |
| US-20240192216-A1 | METABOLIC BIOMARKER SET FOR ASSESSING OVARIAN CANCER | BIOCRATES LIFE SCIENCES AG (AT) | 2024-06-13 | — | — | US | disclosed |
| US-20240142469-A1 | METABOLIC BIOMARKERS FOR ASSESSING HEART FAILURE IN A SINGLE VENTRICLE PEDIATRIC SUBJECT | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-05-02 | — | — | US | disclosed |
| EP-3775906-B1 | METABOLITE-BASED BREAST CANCER DETECTION AND DIAGNOSIS | BURWINKEL BARBARA (DE) | 2023-08-30 | — | — | EP | disclosed |
| US-11519899-B2 | Metabolomics profiling of central nervous system injury | LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) | 2022-12-06 | — | — | US | disclosed |
| US-11506665-B2 | Metabolic biomarker set for assessing ovarian cancer | BIOCRATES LIFE SCIENCES AG (AT) | 2022-11-22 | — | — | US | disclosed |
| US-11493516-B2 | Biomarkers for assessing breast cancer | METABOLOMYCS, INC (US) | 2022-11-08 | — | — | US | disclosed |
| US-11481701-B2 | Computer-based dynamic data analysis | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-10-25 | — | — | US | disclosed |
| US-20220187315-A1 | METHODS AND COMPOSITIONS FOR DIAGNOSING DEPRESSION | DUKE UNIVERSITY | 2022-06-16 | — | — | US | disclosed |
| WO-2015150360-A1 | BIOMARKERS FOR ASSESSING HIV | IDCGS CLINICA DE DIAGNOSTICOS MEDICOS (BR) | 2015-10-08 | — | — | WO | disclosed |
| EP-2927691-A1 | Biomarkers for assessing HIV | IDCGS clinica de Diagnosticos Medicos (BR) | 2015-10-07 | — | — | EP | disclosed |
| US-20140297195-A1 | Method and Use of Metabolites for the Diagnosis of Inflammatory Brain Injury in Preterm Born Infants | INFANDX AG (DE) | 2014-10-02 | — | — | US | disclosed |
| WO-2014071384-A1 | COMPUTER-BASED DYNAMIC DATA ANALYSIS | RINALDO PIERO (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20130164856-A1 | METHOD OF PROCESSING DRIED SAMPLES USING DIGITAL MICROFLUIDIC DEVICE | THE GOVERNING COUNCIL OF THE UNIVERSITH OF TORONTO (CA) | 2013-06-27 | — | — | US | disclosed |
| US-20120214870-A1 | METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2012-08-23 | — | — | US | disclosed |
| US-20120208282-A1 | Method For Normalization in Metabolomics Analysis Methods with Endogenous Reference Metabolites. | BIOCRATES LIFE SCIENCES AG | 2012-08-16 | — | — | US | disclosed |
| US-20120136581-A1 | Method of Diagnosing Asphyxia | BIOCRATES LIFE SCIENCES AG (AT) | 2012-05-31 | — | — | US | disclosed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | disclosed |